20-204

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

1232.55 €

20-229

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

1232.55 €

97-077

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

Nucleocapsid protein is a most abundant protein of coronavirus. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. While screening for ADP-ribosylated proteins during coronavirus (CoV) infection, we identified as the viral nucleocapsid (N) protein. Novel post-translation modification of the CoV N protein that may play a regulatory role for this important structural protein. The array of diverse functional activities accommodated in the hantaviral N protein goes far beyond to be a static structural protein and makes it an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.

1375.72 €

MBS154799-5x1Set

SARS-CoV-2 (COVID-19) Nucleocapsid Matched Pair

5492.38 €

MBS154800-1Set

SARS-CoV-2 (COVID-19) Nucleocapsid Matched Pair

1339.38 €

MBS154800-5x1Set

SARS-CoV-2 (COVID-19) Nucleocapsid Matched Pair

5492.38 €